Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

NARecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2028

Conditions
Tardive DyskinesiaRepetitive Transcranial Magnetic Stimulation
Interventions
DEVICE

repetitive Transcranial Magnetic Stimulation

"Patients will receive rTMS treatment for a total of 14 days. Prior to treatment, patients will undergo an MRI scan; the images will be preprocessed to construct a structural network, and precise localization of the pre-SMA (preSupplementary Motor Area) region and the SCAN (Somatosensory-Cognitive-Action Network) will be performed based on coordinates.~Participants will receive two treatment sessions per day, with an interval of at least 1 hour between each session. Each treatment session consists of 3 cTBS (Continuous theta-Burst Stimulation) treatments, and the interval between each cTBS treatment is at least 15 minutes. Each cTBS treatment lasts 40 seconds, comprising 3 pulses at 50 Hz, repeated every 200 ms (equivalent to 5 Hz), totaling 600 pulses per cTBS treatment. Accordingly, patients receive a total of 3,600 pulses per day, and a cumulative total of 50,400 pulses are delivered throughout the entire treatment period."

Trial Locations (1)

Unknown

RECRUITING

Peking University Sixth Hosptial, Beijing

All Listed Sponsors
lead

Peking University Sixth Hospital

OTHER

NCT07173920 - Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD | Biotech Hunter | Biotech Hunter